Eight Kilometers, Eight Stations, One Metabolic Reset

Keywords: HYROX, Metabolic Health, Insulin Resistance, Functional Fitness, Longevity

Introduction

The global prevalence of metabolic disease has reached epidemic proportions. According to the International Diabetes Federation, an estimated 537 million adults currently live with diabetes, with projections indicating a rise to 783 million by 2045. Metabolic syndrome, characterised by central adiposity, dyslipidaemia, hypertension, and impaired fasting glucose affects approximately 25% of the global adult population and substantially increases the risk of cardiovascular disease, non-alcoholic fatty liver disease, and all-cause mortality. Physical inactivity has been identified as the fourth leading risk factor for global mortality, contributing to approximately 3.2 million deaths annually [1,2,3].

While the therapeutic value of exercise is well-established, the challenge of exercise prescription in clinical settings persists. Adherence to conventional aerobic or resistance training programmes is limited by motivational barriers, time constraints, monotony, and the absence of competitive or social incentives. In this context, novel exercise formats that integrate multiple training modalities with gamified or competitive elements represent a promising frontier in preventive medicine and metabolic health management [4].

HYROX, derived from the Greek “hyper” (beyond) and “oxygonos” (challenge) is a standardised fitness competition and training format founded in Germany in 2017. The event requires athletes to complete eight rounds of 1 km running, each followed by one of eight prescribed functional fitness stations: SkiErg (1,000 m), sled push (50 m), sled pull (50 m), burpee broad jumps (80 m), rowing (1,000 m), farmer’s carry (200 m), sandbag lunges (100 m), and wall ball shots (75–100 repetitions). This format demands sustained aerobic output, muscular endurance, and neuromuscular coordination, placing unique and comprehensive physiological demands on the participant [5].

Despite its rapid global adoption with events now held across more than 50 countries and over 600,000 registered athletes the scientific literature examining HYROX as a metabolic health intervention remains nascent. This review aims to synthesise existing evidence on concurrent and hybrid training modalities relevant to the HYROX format, elucidate the mechanistic pathways through which HYROX training confers metabolic benefits, and provide clinicians and practitioners with an evidence-based framework for HYROX training prescription in metabolic disease prevention and management.

HYROX: Structure, Format, and Physiological Profile

The HYROX event is standardized globally, allowing for direct comparison across participants and populations, a methodological advantage over many free-format functional fitness protocols. The full competition covers approximately 8 km of running interspersed with eight functional stations, resulting in total work duration ranging from approximately 55 minutes in elite athletes to over 100 minutes in recreational participants. This duration positions HYROX within the moderate-to-long duration, moderate-to-high intensity exercise domain, engaging both oxidative and glycolytic metabolic pathways simultaneously [5].

Heart rate monitoring during HYROX events consistently demonstrates sustained elevations at 80–93% of maximum heart rate, with brief spikes exceeding 95% during high-demand stations such as sled push and burpee broad jumps. These intensities correspond to lactate threshold and supramaximal exercise zones, conditions known to elicit significant metabolic and cardiovascular adaptations. Mean energy expenditure has been estimated at 600–900 kcal per event, with individual variability driven by body mass, training status, and competition pace[6].

The HYROX workout stations are strategically sequenced to alternate between upper-body dominant, lower-body dominant, and full-body movements. This design ensures broad recruitment of skeletal muscle mass, a critical factor in metabolic health, given that skeletal muscle accounts for up to 80% of insulin-stimulated glucose uptake in the postprandial state. Furthermore, the running segments maintain continuous cardiovascular engagement, preventing full recovery between stations and sustaining an elevated metabolic rate throughout the event [7].

Station/ Segment	Distance or Volume	Primary Energy System	Primary Muscle Groups
Running (x8)	1,000 m per lap (8 km total)	Oxidative phosphorylation	Lower limb, cardiovascular
SkiErg	1,000 m	Aerobic/glycolytic	Latissimus dorsi, core, arms
Sled Push	50 m	Phosphocreatine/glycolytic	Quadriceps, glutes, chest
Sled Pull	50 m	Phosphocreatine/glycolytic	Hamstrings, back, biceps
Burpee Broad Jumps	80 m	Glycolytic/aerobic	Full body, cardiovascular
Rowing (Ergometer)	1,000 m	Aerobic/ glycolytic	Posterior chain, core, arms
Farmer’s Carry	200 m	Glycolytic/aerobic	Forearms, trapezius, core
Sandbag Lunges	100 m	Glycolytic/aerobic	Quadriceps, glutes, hamstrings
Wall Ball Shots	75-100 steps	Glycolytic/aerobic	Quadriceps, deltoids, core

Table 1. HYROX Competition Format: Stations and Primary Metabolic Demands

Metabolic Adaptations Induced by Concurrent and High-Intensity Functional Training

HYROX training mirrors the concurrent training (CT) model, defined as the integration of endurance and resistance exercise within a single session or training programme. A landmark meta-analysis by Wilson et al. (2012) encompassing 21 studies demonstrated that CT produces superior improvements in body composition, including reductions in body fat percentage and increases in lean muscle mass, compared with either modality performed in isolation. The dual stimulus of CT is mechanistically significant: endurance exercise activates AMP-activated protein kinase (AMPK) signalling pathways promoting mitochondrial biogenesis, fatty acid oxidation, and glucose transporter type 4 (GLUT4) translocation, while resistance exercise activates the mechanistic target of rapamycin complex 1 (mTORC1) pathway, driving muscle protein synthesis and hypertrophy [8,9].

The high-intensity functional training (HIFT) model, of which HYROX is a structured exemplar, has been associated with marked post-exercise excess oxygen consumption (EPOC), reflecting an elevated metabolic rate for 12–48 hours following exercise. Laforgia et al. demonstrated that high-intensity exercise generates significantly greater EPOC magnitude and duration compared with continuous moderate-intensity aerobic work, translating into substantially increased total energy expenditure over a 24-hour period. This phenomenon is particularly relevant in the context of metabolic disease management, where increasing total energy expenditure without disproportionately increasing training volume is clinically desirable [10].

Mitochondrial biogenesis represents another critical metabolic adaptation induced by hybrid training formats. The transcriptional coactivator peroxisome proliferator-activated receptor-gamma coactivator 1-alpha (PGC-1α) is upregulated following both endurance and resistance exercise, stimulating mitochondrial density and oxidative enzyme activity in skeletal muscle. Individuals with T2DM and metabolic syndrome exhibit well-documented mitochondrial dysfunction characterised by reduced mitochondrial density, impaired electron transport chain activity, and elevated reactive oxygen species (ROS) production. HYROX training, by consistently stimulating PGC-1α across multiple physiological pathways, may represent a uniquely efficient intervention for restoring mitochondrial function in at-risk populations [11,12]

HYROX and Glycaemic Control: Insulin Sensitivity and Glucose Metabolism

Skeletal muscle is the predominant site of peripheral glucose disposal, accounting for 70–80% of insulin-mediated glucose uptake under euglycaemic hyperinsulinaemic clamp conditions. Exercise-induced GLUT4 translocation to the sarcolemma occurs via both insulin-dependent and insulin-independent mechanisms, the latter mediated by AMPK and calcium-calmodulin dependent protein kinase II (CaMKII) activation during muscle contraction. This independent pathway is of particular clinical relevance, as it enables glucose uptake even in the setting of severe insulin resistance [7,13].

High-intensity resistance training, a dominant component of HYROX, has been demonstrated to increase GLUT4 protein content in skeletal muscle by 60–369% in individuals with T2DM, with corresponding improvements in insulin-mediated glucose uptake of up to 40%. Holten et al. (2004) conducted a randomised controlled trial demonstrating that six weeks of unilateral resistance training produced significant increases in insulin signalling protein abundance (IRS-1, PI3-K p85α) and GLUT4 content in trained versus untrained limbs, providing compelling mechanistic evidence for the local adaptations driving improved glycaemic control [14].

The running component of HYROX contributes additional glycaemic benefits through its sustained activation of fatty acid oxidation and glycogen resynthesis pathways. Studies examining high-intensity interval training (HIIT), physiologically analogous to the intermittent high-intensity running inherent in HYROX demonstrate acute reductions in postprandial blood glucose that persist for 24–72 hours following exercise. A systematic review and meta-analysis by Batacan et al. (2017) confirmed that HIIT significantly reduces fasting blood glucose, fasting insulin, and HOMA-IR compared with sedentary controls, with effect sizes comparable to or exceeding those of moderate-intensity continuous training (MICT) [15,16].

The practical implication for HYROX training is compelling: the combination of resistance-driven GLUT4 upregulation, AMPK-mediated non-insulin-dependent glucose disposal during exercise, and prolonged post-exercise insulin sensitisation creates a uniquely synergistic metabolic environment. Individuals with pre-diabetes or metabolic syndrome may derive particular benefit from this multimodal glucose-lowering effect when HYROX training is integrated systematically into a lifestyle intervention programme.

Body Composition: Effects on Adiposity, Lean Mass, and Visceral Fat

Excess adiposity, particularly central and visceral fat accumulation, is mechanistically linked to insulin resistance, systemic inflammation, and dyslipidaemia through multiple pathways including ectopic lipid deposition, adipokine dysregulation, and portal delivery of free fatty acids to the liver. Reductions in total and visceral adipose tissue represent key therapeutic targets in metabolic disease management. Exercise-induced fat loss is mediated by caloric expenditure, catecholamine-stimulated lipolysis, and long-term increases in resting metabolic rate (RMR) through lean mass accretion [17,18].

HYROX training’s combined endurance-resistance structure is particularly well-suited to favourably remodel body composition. The high caloric expenditure of each HYROX session (600–900 kcal) positions it as an energy-intensive intervention, while the substantial resistance loading, particularly in station exercises such as sled push/pull, sandbag lunges, and farmer’s carry provides sufficient mechanical stimulus for muscle protein synthesis and lean mass preservation or accretion. Ross and Janssen demonstrated that exercise-induced fat loss, without dietary restriction, preferentially reduces visceral adipose tissue relative to subcutaneous fat, an effect mediated by catecholamine sensitivity in the visceral adipocyte pool [19].

HIIT and HIFT protocols have consistently demonstrated superior visceral fat reduction compared with isocaloric moderate-intensity continuous training. Tremblay et al. found that HIIT participants achieved six times greater subcutaneous fat loss per unit of energy expenditure compared with MICT participants, suggesting that metabolic adaptations beyond direct caloric burn including hormonal, enzymatic, and mitochondrial factors account for the disproportionate fat reduction observed with high-intensity modalities. These findings directly support the metabolic body composition benefits attributable to HYROX-style training programmes [20].

Lean mass preservation is equally important in the metabolic health context. Muscle mass inversely correlates with insulin resistance, all-cause mortality, and risk of metabolic syndrome, in part because skeletal muscle serves as the primary site of postprandial glucose disposal and fatty acid oxidation. The resistance-based stations in HYROX deliver sufficient eccentric and concentric loading across major muscle groups to stimulate mTORC1-mediated anabolism, supporting lean mass maintenance even in caloric deficit, a key advantage over purely aerobic training approaches [7].

Cardiovascular and Cardiometabolic Benefits

Cardiovascular disease (CVD) remains the leading cause of mortality globally, with metabolic syndrome conferring a two- to three-fold increase in CVD risk. Exercise training exerts broad beneficial effects on modifiable cardiovascular risk factors including systolic and diastolic blood pressure, resting heart rate, left ventricular function, endothelial function, lipid profiles, and inflammatory biomarkers. The intensity and modality of exercise are critical determinants of the magnitude of these adaptations [2,21].

HYROX training sustains cardiovascular output at 80–93% of maximum heart rate for extended durations, providing a robust stimulus for cardiac remodelling. Repeated exposure to high cardiac workloads drives physiological left ventricular hypertrophy (increased stroke volume and chamber volume), reduced resting heart rate, and improved cardiac output, adaptations collectively termed “athlete’s heart” and associated with significantly reduced CVD risk. The sustained high-intensity cardiovascular demands of HYROX additionally stimulate endothelial nitric oxide synthase (eNOS) expression, promoting vasodilation and reducing systemic vascular resistance, a mechanistic basis for the antihypertensive effects of high-intensity exercise [21,22].

Regarding lipid metabolism, high-intensity training has been consistently associated with increases in high-density lipoprotein cholesterol (HDL-C) and reductions in triglyceride levels, effects mediated by increased lipoprotein lipase (LPL) activity in skeletal muscle and adipose tissue. A meta-analysis by Kelley et al. (2005) encompassing 52 randomised controlled trials demonstrated that exercise training significantly reduces total cholesterol, LDL-C, and triglycerides while increasing HDL-C, with greater effect sizes observed for higher-intensity protocols.(23) The multimodal nature of HYROX training, combining both aerobic and resistance-based lipid mobilisation stimuli, is expected to confer additive benefits on the lipid profile compared with unimodal approaches [23].

Chronic systemic inflammation, indexed by C-reactive protein (CRP), interleukin-6 (IL-6), and tumour necrosis factor-alpha (TNF-α), is a hallmark of metabolic syndrome and an independent CVD risk factor. Regular vigorous exercise significantly reduces circulating inflammatory cytokines through multiple mechanisms, including reductions in adipose tissue mass (a primary source of pro-inflammatory adipokines), increased anti-inflammatory myokine secretion (notably IL-6 from contracting muscle), and autonomic nervous system modulation. HYROX training, through its capacity to simultaneously reduce visceral fat and stimulate myokine production across a broad muscle mass, may represent an especially potent anti-inflammatory intervention [24].

VO₂max Enhancement and Mitochondrial Adaptations

Maximal aerobic capacity (VO₂max) is one of the strongest predictors of all-cause and cardiovascular mortality, outperforming traditional risk factors including hypertension, dyslipidaemia, and smoking in prospective cohort studies.(25) Each 1 MET increase in cardiorespiratory fitness has been associated with an approximately 13% reduction in all-cause mortality and a 15% reduction in CVD mortality, underscoring VO₂max as a critical therapeutic target in longevity medicine [25].

HYROX training produces significant improvements in VO₂max through its sustained high-intensity cardiovascular demands. The running component, comprising 8 km at race pace, activates central cardiovascular adaptations including increased maximal stroke volume, cardiac output, and arteriovenous oxygen difference. The anaerobic threshold stimulus provided by HYROX intensity levels (consistently near or above the second ventilatory threshold) is well-established as a driver of superior VO₂max improvement compared with moderate-intensity exercise.(26) Laursen and Jenkins demonstrated that training at intensities above 85% VO₂max produces significantly greater improvements in both VO₂max and running economy compared with isocaloric training at 70% VO₂max [27].

At the skeletal muscle level, repeated HYROX training sessions stimulate PGC-1α-mediated mitochondrial biogenesis, increasing mitochondrial density, cristae surface area, and oxidative enzyme (citrate synthase, succinate dehydrogenase) activity. These adaptations enhance the capacity for fatty acid oxidation, reduce reliance on glycolytic ATP generation at submaximal intensities, and improve metabolic flexibility , the ability to switch efficiently between carbohydrate and fat oxidation according to substrate availability. Metabolic inflexibility, defined as impaired substrate switching, is a cardinal feature of insulin resistance and obesity and represents an independent therapeutic target in metabolic disease management [11].

Psychosocial Benefits, Adherence, and the Role of Competitive Format

Beyond physiological adaptations, the long-term efficacy of any exercise intervention is contingent upon sustained adherence. Traditional exercise programmes are characterised by high drop-out rates, with population surveys consistently demonstrating that fewer than 25% of adults meet current physical activity guidelines. Barriers to adherence include lack of motivation, social isolation, absence of goal-setting, and perceived monotony of conventional exercise formats [3,4].

HYROX addresses these barriers through several psychologically compelling mechanisms. First, its competitive and event-based structure provides extrinsic motivational scaffolding, a defined goal (the race) around which training can be periodised, offering progressive milestones and measurable performance improvement. The well-established psychological benefits of goal-setting theory, as articulated by Locke and Latham, are directly applicable to HYROX preparation and competition [28].

Second, HYROX’s community-based training ecosystem, including group classes, team categories in competition, and online training communities provides social support and accountability, factors consistently associated with improved exercise adherence in both healthy adults and clinical populations. Third, the quantifiable, standardised nature of the HYROX format enables performance tracking over time, supporting intrinsic motivation through progressive competence and mastery [4].

Exercise has well-documented benefits on mental health, including reductions in depressive and anxiety symptoms mediated by endorphin release, HPA axis modulation, neurogenesis in the hippocampus, and social engagement. For individuals with metabolic disease who carry elevated rates of comorbid depression and anxiety, the psychosocial architecture of HYROX may confer additional health benefits beyond the direct metabolic effects of exercise itself, while simultaneously improving the likelihood of sustained long-term participation [29].

Evidence-Based HYROX Training Regimen for Metabolic Health

Exercise has well-documented benefits on mental health, including reductions in depressive and anxiety symptoms mediated by endorphin release, HPA axis modulation, neurogenesis in the hippocampus, and social engagement. For individuals with metabolic disease, who carry elevated rates of comorbid depression and anxiety, the psychosocial architecture of HYROX may confer additional health benefits beyond the direct metabolic effects of exercise itself, while simultaneously improving the likelihood of sustained long-term participation [29].

Phase 1: Foundation (Weeks 1-6) : Base Aerobic and Movement Conditioning

The primary objectives of Phase 1 are to establish aerobic base, develop movement competency in HYROX-specific exercises, and introduce the body to concurrent training stress. Training frequency is set at 4 sessions per week (3 HYROX-specific + 1 active recovery). Running volume begins at 15–20 km per week at conversational pace (65–70% HRmax), gradually progressing to 25 km per week by Week 6. Two resistance training sessions per week focus on movement patterns specific to HYROX stations (goblet squats, Romanian deadlifts, rowing ergometer work, farmer’s carry progression). Intensity is kept moderate (RPE 5–6/10); duration per session is 45–60 minutes.

Phase 2: Build (Weeks 7-14): Threshold and Lactate Training

Phase 2 introduces threshold and lactate-level training to improve VO₂max, lactate clearance, and muscular endurance. Training frequency increases to 5 sessions per week. Running workouts include one tempo run per week (20–30 min at 80–85% HRmax), one interval session (6–8 x 1 km at 90–95% HRmax), and one long run (45–75 min at 70–75% HRmax). HYROX simulation sessions (mini-HYROX: 4 rounds of 1 km + 4 stations) are introduced twice per week, focusing on transition efficiency and maintaining pace under fatigue. Resistance loads are progressively increased; emphasis is placed on loaded carries and sled work. Total session duration is 60–75 minutes at RPE 7–8/10.

Phase 3: Race-Specific Preparation (Weeks 15-20): Competition Simulation and Peaking

Phase 3 focuses on race-pace specificity, metabolic efficiency, and psychological readiness. Full HYROX simulation events (8 x 1 km + 8 stations) are conducted monthly under race conditions. High-intensity interval work is maintained but volume is modulated according to individual recovery markers. Station-specific technique refinement addresses individual limiting factors. Nutritional strategies, including carbohydrate timing, intra-event fuelling, and post-event recovery nutrition are systematically practised. A 1-week taper (40–50% volume reduction, maintenance of intensity) precedes competition.

Phase	Weeks	Key Focus	Sessions/Week	Intensity (HRmax)
Phase 1: Foundation	1-6	Aerobic base, movement competency	4	65-75%
Phase 2: Build	7-14	Threshold, lactate, simulation	5	75-90%
Phase 3: Peak	15-20	Race specificity, taper	4-5	80-95% (with taper)

Table 2. Summary of 20-Week HYROX Training Regimen for Metabolic Health

Nutritional Considerations for Metabolic Optimization in HYROX Training

Nutritional strategy is integral to maximising the metabolic health benefits of HYROX training. For individuals with metabolic disease risk, several evidence-based nutritional principles are particularly relevant. Adequate protein intake (1.6–2.2 g/kg body weight/day) is essential to support the anabolic demands of resistance training and preserve lean mass during periods of energy deficit.(30) Protein distribution across meals (25–40 g per meal) further optimises muscle protein synthesis by maximising leucine-stimulated mTORC1 activation at each feeding occasion.

Carbohydrate periodisation, the strategic manipulation of carbohydrate availability in alignment with training demands is a well-established tool for metabolic adaptation. Training in a low-glycogen state (e.g., fasted morning sessions or post-depletion training) amplifies AMPK and PGC-1α signalling, promoting mitochondrial biogenesis and fat oxidative capacity. Conversely, high-quality carbohydrate availability around high-intensity HYROX sessions supports performance and accelerates glycogen resynthesis. For individuals with insulin resistance, a lower-carbohydrate, higher-protein dietary approach aligned with HYROX training timing may synergistically improve glycaemic control [31].

Hydration status significantly impacts exercise performance and metabolic function. A fluid deficit of as little as 2% of body weight impairs aerobic performance and cognitive function. Given the substantial sweat rates during HYROX training (1–2.5 L/hour), personalised hydration strategies incorporating electrolyte replacement are recommended. Anti-inflammatory dietary patterns, including the Mediterranean diet and diets rich in omega-3 fatty acids, polyphenols, and dietary fibre, complement the exercise-induced anti-inflammatory effects of HYROX training and are strongly supported by evidence for metabolic disease prevention and management [32].

Safety Considerations, Contraindications, and Clinical Monitoring

HYROX training involves high-intensity, high-volume exercise that carries inherent risks of musculoskeletal injury, overtraining, and cardiovascular events if implemented inappropriately. Prospective injury data from competitive HYROX events indicate that the most common injuries involve the lower extremities (knee, ankle), shoulder, and lower back, consistent with the biomechanical demands of the event’s stations. Adequate movement screening, progressive loading, and attention to technique in sled and loaded carry exercises are essential injury prevention measures.

For individuals with cardiovascular disease or significant CVD risk factors, exercise stress testing prior to initiating high-intensity training is recommended in accordance with guidelines from the American College of Sports Medicine (ACSM). Absolute contraindications to high-intensity exercise include unstable angina, decompensated heart failure, severe symptomatic aortic stenosis, and uncontrolled hypertension (BP >180/110 mmHg at rest). Relative contraindications requiring physician consultation include known cardiac arrhythmias, hypertrophic cardiomyopathy, and pulmonary hypertension [33].

For individuals with T2DM, blood glucose monitoring before and after HYROX sessions is advised, particularly in those receiving insulin or sulphonylurea therapy, given the risk of exercise-induced hypoglycaemia. Blood glucose levels below 5.6 mmol/L (100 mg/dL) prior to exercise warrant carbohydrate supplementation. Conversely, high-intensity exercise may paradoxically increase blood glucose acutely in individuals with poorly controlled diabetes due to catecholamine-mediated hepatic glucose output; this response is self-limiting and should not deter participation but warrants monitoring [34].

Conclusion

HYROX represents a paradigm-shifting exercise modality that uniquely integrates the metabolic benefits of endurance and resistance training within a standardised, competitive, and socially engaging format. The physiological evidence strongly supports its capacity to improve insulin sensitivity, reduce visceral adiposity, enhance cardiorespiratory fitness, stimulate mitochondrial biogenesis, and ameliorate systemic inflammation, the core therapeutic targets in metabolic disease prevention and management.

For clinicians and health practitioners in longevity and preventive medicine, HYROX training offers a compelling, evidence-grounded tool for exercise prescription in individuals at metabolic risk. Its scalable format, broad demographic appeal, and measurable outcomes align with the precision medicine paradigm increasingly central to modern preventive health. A phased, periodised 20-week training regimen, spanning aerobic foundation, lactate threshold development, and race-specific preparation provides a structured and clinically rational pathway for metabolic health optimisation.

As HYROX continues its global expansion, the scientific community is presented with a unique opportunity to study a real-world, population-scale exercise intervention with standardised and measurable outcomes. Investment in HYROX-specific clinical research, particularly in metabolically compromised cohorts, is strongly warranted and may yield significant advances in our understanding of optimised exercise

Reference

1. International Diabetes Federation. IDF Diabetes Atlas, 10th edn. Brussels: IDF; 2021.

2. Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention. Circulation. 2009;120(16):1640–5.

3. World Health Organization. Global health risks: mortality and burden of disease attributable to selected major risks. Geneva: WHO Press; 2009.

4. Trost SG, Owen N, Bauman AE, Sallis JF, Brown W. Correlates of adults’ participation in physical activity: review and update. Med Sci Sports Exerc. 2002;34(12):1996–2001.

5. HYROX GmbH. HYROX Official Competition Format. Hamburg: HYROX GmbH; 2023. Available from: https://hyrox.com

6. Tibana RA, de Almeida LM, Balsamo S, Nascimento DC, de Sousa NM, Thomas SG, et al. Two consecutive days of functional fitness training does not affect metabolic, performance and muscle damage markers in recreationally active men. PeerJ. 2015;3:e1180.

7. DeFronzo RA, Jacot E, Jequier E, Maeder E, Wahren J, Felber JP. The effect of insulin on the disposal of intravenous glucose. Results from indirect calorimetry and hepatic and femoral venous catheterization. Diabetes. 1981;30(12):1000–7.

8. Wilson JM, Marin PJ, Rhea MR, Wilson SM, Loenneke JP, Anderson JC. Concurrent training: a meta-analysis examining interference of aerobic and strength exercises. J Strength Cond Res. 2012;26(8):2293–307.

9. Egan B, Zierath JR. Exercise metabolism and the molecular regulation of skeletal muscle adaptation. Cell Metab. 2013;17(2):162–84.

10. Laforgia J, Withers RT, Gore CJ. Effects of exercise intensity and duration on the excess post-exercise oxygen consumption. J Sports Sci. 2006;24(12):1247–64.

11. Lira VA, Benton CR, Yan Z, Bonen A. PGC-1alpha regulation by exercise training and its influences on muscle function and insulin sensitivity. Am J Physiol Endocrinol Metab. 2010;299(2):E145–61.

12. Mootha VK, Lindgren CM, Eriksson KF, Subramanian A, Sihag S, Lehar J, et al. PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat Genet. 2003;34(3):267–73.

13. Richter EA, Hargreaves M. Exercise, GLUT4, and skeletal muscle glucose uptake. Physiol Rev. 2013;93(3):993–1017.

14. Holten MK, Zacho M, Gaster M, Juel C, Wojtaszewski JF, Dela F. Strength training increases insulin-mediated glucose uptake, GLUT4 content, and insulin signaling in skeletal muscle in patients with type 2 diabetes. Diabetes. 2004;53(2):294–305.

15. Gibala MJ, Little JP, Macdonald MJ, Hawley JA. Physiological adaptations to low-volume, high-intensity interval training in health and disease. J Physiol. 2012;590(5):1077–84.

16. Batacan RB Jr, Duncan MJ, Dalbo VJ, Tucker PS, Fenning AS. Effects of high-intensity interval training on cardiometabolic health: a systematic review and meta-analysis of intervention studies. Br J Sports Med. 2017;51(6):494–503.

17. Despres JP, Lemieux I. Abdominal obesity and metabolic syndrome. Nature. 2006;444(7121):881–7.

18. Tremblay A, Simoneau JA, Bouchard C. Impact of exercise intensity on body fatness and skeletal muscle metabolism. Metabolism. 1994;43(7):814–8.

19. Ross R, Janssen I. Physical activity, total and regional obesity: dose-response considerations. Med Sci Sports Exerc. 2001;33(6 Suppl):S521–7.

20. Tremblay A, Simoneau JA, Bouchard C. Impact of exercise intensity on body fatness and skeletal muscle metabolism. Metabolism. 1994;43(7):814–8.

21. Pescatello LS, Franklin BA, Fagard R, Farquhar WB, Kelley GA, Ray CA. Exercise and hypertension. Med Sci Sports Exerc. 2004;36(3):533–53.

22. Maron BJ, Pelliccia A. The heart of trained athletes: cardiac remodeling and the risks of sports, including sudden death. Circulation. 2006;114(15):1633–44.

23. Kelley GA, Kelley KS, Tran ZV. Aerobic exercise and lipids and lipoproteins in women: a meta-analysis of randomized controlled trials. J Womens Health (Larchmt). 2004;13(10):1148–64.

24. Pedersen BK, Saltin B. Exercise as medicine – evidence for prescribing exercise as therapy in 26 different chronic diseases. Scand J Med Sci Sports. 2015;25(S3):1–72.

25. Myers J, Prakash M, Froelicher V, Do D, Partington S, Atwood JE. Exercise capacity and mortality among men referred for exercise testing. N Engl J Med. 2002;346(11):793–801.

26. Wisloff U, Stoylen A, Loennechen JP, Bruvold M, Rognmo O, Haram PM, et al. Superior cardiovascular effect of aerobic interval training versus moderate continuous training in heart failure patients. Circulation. 2007;115(24):3086–94.

27. Laursen PB, Jenkins DG. The scientific basis for high-intensity interval training: optimising training programmes and maximising performance in highly trained endurance athletes. Sports Med. 2002;32(1):53–73.

28. Locke EA, Latham GP. Building a practically useful theory of goal setting and task motivation. A 35-year odyssey. Am Psychol. 2002;57(9):705–17.

29. Blumenthal JA, Babyak MA, Doraiswamy PM, Watkins L, Hoffman BM, Barbour KA, et al. Exercise and pharmacotherapy in the treatment of major depressive disorder. Psychosom Med. 2007;69(7):587–96.

30. Morton RW, Murphy KT, McKellar SR, Schoenfeld BJ, Henselmans M, Helms E, et al. A systematic review, meta-analysis and meta-regression of the effect of protein supplementation on resistance training-induced gains in muscle mass and strength in healthy adults. Br J Sports Med. 2018;52(6):376–84.

31. Hawley JA, Hargreaves M, Joyner MJ, Zierath JR. Integrative biology of exercise. Cell. 2014;159(4):738–49.

32. Esposito K, Maiorino MI, Bellastella G, Chiodini P, Panagiotakos D, Giugliano D. A journey into a Mediterranean diet and type 2 diabetes: a systematic review with meta-analyses. BMJ Open. 2015;5(8):e008222.

33. Riebe D, Franklin BA, Thompson PD, Garber CE, Whitfield GP, Magal M, et al. Updating ACSM’s recommendations for exercise preparticipation health screening. Med Sci Sports Exerc. 2015;47(11):2473–9.34. Colberg SR, Sigal RJ, Yardley JE, Riddell MC, Dunstan DW, Dempsey PC, et al. Physical activity/exercise and diabetes: a position statement of the American Diabetes Association. Diabetes Care. 2016;39(11):2065–79.